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Abstract
Introduction: The present study was aimed to characterize the clinicopatholog-
ical, immunohistochemical features and treatment outcomes of primary oral
and maxillofacial liposarcomas by presenting the experience over a 16-year peri-
od at a tertiary referral Chinese institution for head neck cancer.
Material and methods: This retrospective clinical study included 11 cases of
pathologically confirmed primary liposarcomas treated from January 1993 to
September 2009. Detailed information regarding primary site, clinical manifes-
tations, histopathological and immunohistochemical analysis, treatments and
prognosis was collected and reported.
Results: Eight female and 3 male patients aged from 8 to 76 years old. These
lesions occurred in buccal (3), parotid (2), temporal (2), tongue (2), palate (1)
and oropharyngeal (1) region. They were histopathologically categorized into 
4 subtypes based on WHO classification scheme: atypical lipomatous tumor/well-
differentiated (4), myxoid (4), mixed-type (2) and pleomorphic (1) liposarcomas.
Immunohistochemical staining indicated mostly positive for Vimentin and 
S-100 but negative for other markers. Most patients presented as slow-grow-
ing painless masses and underwent surgery alone or combined with postoper-
ative radiotherapy. Two patients were misdiagnosed and inappropriate treated
and developed local relapse before referred to our institute. No distant metas-
tasis and one disease-related death were recorded during the follow-up (ranging:
1-11 years, mean: 4.5 years).
Conclusions: Oral and maxillofacial liposarcoma is exceedingly rare and has
atypical clinical manifestations but characteristic histopathology. Complete exci-
sion with negative margins followed by long-term follow-up is recommended
as the treatment of choice for these uncommon entities. 
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Introduction
Liposarcoma represents one of the most common mesenchymal malig-
nant neoplasms, approximately accounting for 20% of all soft tissue sar-
comas [1]. It predominantly occurs in the extremities and retroperitoneum
and is extremely rare in the oral and maxillofacial region. To our knowl-
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edge, only limited case reports and small series of
primary liposarcomas involved in this anatomic
region have been previously published [2-7]. The
comprehensive clinicopathological information as
well as treatment modalities and outcomes of this
uncommon malignancy were poorly described thus
far. Moreover, the rarity of liposarcoma together
with its frequently atypical clinical presentations
may probably lead to misdiagnosis and inappropri-
ate management with compromised prognosis.
Therefore, a more thorough understanding of the
epidemiology, histopathological characteristics of
oral and maxillofacial liposarcoma is urgently
required to optimize the diagnosis and treatment
strategies to achieve better outcomes.
Liposarcomas within oral and maxillofacial region
usually present as slow-growing painless mass in
individuals with a peak incidence between 40 and
60 years of age [8]. A male preponderance and buc-
cal mucosa as the site of predilection for them were
reported [3, 9]. Advances in genetic and molecular
investigation have revealed that liposarcoma is
a heterogeneous group of tumors composed of five
histological subtypes with distinct morphology,
cytogenetic abnormalities and clinical features as
shown in the latest WHO classification for soft tis-
sue sarcoma [10]. The precise diagnosis of liposar-
coma relies heavily on the histopathological exam-
ination before or after surgery. Complete surgical
excision remains the mainstream treatment modal-
ity for liposarcomas [11]. However, no consensus
about the optimized treatment options and proper
prognosis prediction for these malignancies exists
until now.
In the present study, the clinicopathological and
immunohistochemical data, clinical presentation,
treatments and disease-specific outcomes regard-
ing primary oral and maxillofacial liposarcomas
treated in a tertiary referral Chinese hospital were
reported in detail. 
Material and methods
The oral and maxillofacial tumor registry of
Shanghai Ninth people’s hospital affiliated to
Shanghai Jiao Tong University was searched and
relevant medical records were reviewed to retrieve
information for patients diagnosed as primary oral
and maxillofacial liposarcomas between January
1993 and September 2009. Inclusion criteria com-
prised an oral and maxillofacial location for primary
lesion and definitive diagnosis by established
pathological criteria for liposarcoma. The archived
H&E and immunohistochemical slides available
were further retrieved and reviewed independent-
ly by the senior oral pathologists. The research pro-
tocol was approved by the Institutional Review
Committee of Shanghai Jiao Tong University Med-
ical School. Informed consents were obtained from
patients or patient relatives. The clinical and fol-
low-up information of these patients including
demographics, primary tumor site, histological sub-
types, treatment modality and outcomes from med-
ical records were collected and presented. 
During surgery, these lesions were excised about
1.5 cm away from the tumor margin. After surgical
removal of the lesions, the tissue specimen were
immediately transferred to oral pathology unit and
subjected to pathological examination by frozen
sections. The three-dimensional margins were also
determined by frozen sections to avoid possible
residual tumor. After surgery, the surgical samples
were fixed in 10% buffered formalin and sectioned
in 4-μm slides for hematoxylin-eosin staining and
immunohistochemical staining using standard pro-
cedures. The commercial available antibodies to
Vimentin, S-100, CD34, CD99, smooth-muscle actin
(SMA), CKpan, Desmin, muscle-specific actin (MSA)
were used together with DAB staining system with
appropriate positive and negative controls.
Immunoreactivity for each protein was determined
based on the proportion of stained cells and expect-
ed subcellular locations. Negative control was pre-
pared using phosphate buffer solution (PBS) instead
of primary and second antibodies. 
Most patients in this series underwent complete
local excision with disease-free margins. To reduce
the possibility of local recurrence, postoperative
radiotherapy (about 55-60 Gy) was administered to
selected cases. Two recurrent patients who were
misdiagnosed and inappropriate treated in local
hospital were received another surgical resection
in our institute followed by chemotherapy. Large
lesions which were more than 5 cm in largest
dimension in other two patients and they were rec-
ommended for radiotherapy after surgery. No
chemotherapy before and after surgery were given
due to the insensitiveness of liposarcoma to chem-
ical agents. All patients were recommended to par-
ticipate in long-term follow-up at regular intervals. 
Results
Demographic and clinical features
Through tumor registry search and further
pathological confirmation of initial diagnosis, eleven
cases of primary oral and maxillofacial liposarco-
mas were enrolled and briefly showed in Table I.
Eight patients were females and the others were
males, indicating a female predominance (8 : 3).
The mean age of patients were 33.7 years. The
lesions were found in buccal mucosa (3), temporal
(2), parotid (2), ventral tongue (2), palate (1) and
the lateral pharyngeal wall (1). Clinical manifesta-
tions of this malignancy varied largely depending
on the areas involved. Most lesions typically began
as slowly-growing and painless masses with dif-
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ferent intervals between tumor onset and clinical
presentation. The main reasons for patients to seek
treatment were accelerated growth of masses and
resulting facial disfigurement and the development
of pain. Liposarcoma in the parotid region often
resembled a begin tumor without obvious facial
nerve paralysis. However, when large parotid lesions
extended toward parapharygeal space or para-
pharygeal liposarcoma developed, diverse severities
of airway obstruction, dysphagia and night snoring
occurred (Figure 1). Computed tomography (CT) and
Magnetic resonance imaging (MRI) were usually
employed to determine the precise location and
boundary as well as its relationship with adjacent
tissues. Images of ALT/WD liposarcoma usually
showed similar signal intensity equal to fat that
closely resemble lipoma and characteristic thickened
septa (Figure 1). Other subtypes of liposarcomas
showed no remarkable difference to other soft-tis-
sue malignancies in CT/MRI images. Among these
patients, wide local excision with negative margins
was the most common treatment modality. Radical
resection was carried out for patients with local
recurrence. Postoperative radiotherapy was also
administered to four patients, mainly due to large
lesions and recurrent cases. Follow-up period ranged
from 1 to 11 years (mean: 4.5 years). Ten patients
remained alive until last follow-up, while only 
1 patient died of recurrent lesions adjacent to brain
and cranial base. Two patients had recurrent lesions
about 2-3 months after initial incomplete excision
in local hospital before admitted to our department.
No evidence of distant metastasis was recorded. 
Histopathological and immunohistochemical
findings
Macroscopically, liposarcomas often appeared
as soft-tissue mass containing diverse extent of
hemorrhage and necrosis and varied from well-cir-
cumscribed, multilubolated and partially encapsu-
lated to less well-delineated and more invasive and
infiltrating with adjacent tissue. The colors of tumor
cut surfaces ranged from yellow to grey and from
greasy to mucoid and gelatinous mainly depending
on different histopathologic types. Based on
histopathology and the latest WHO classification
for liposarcoma, eight cases were categorized as
atypical lipomatous tumor/well differentiated
(ALT/WD) and myxoid liposarcoma. Two cases were
subtyped as mixted-type and 1 patient had pleo-
morphic liposarcoma. 
Under microscopy, ALT/WD subtype was char-
acterized by the presence of mature adipocytes
with significant variation in cell size and scattered
nuclear atypia and variable number of atypical
stromal cells (Figure 2). The atypical stromal cells
were spindle and often identified with hyper-
chromatic nuclei embedded within mature adipose
tissue. Rare scattered and monovacuolated or mul-
tivacuolated lipoblasts could be found. The case
with multiple recurrences was diagnosed as lipo-
ma-like subtype of ALT/WD liposarcoma. No evi-
dence of dedifferentiation of ALT/WD or other
types of malignancy could be detected in the
relapsed lesions. Myxoid liposarcoma consisted
round primitive nonlipogenic mesenchymal cells
and a few small signet-ring lipoblasts within promi-
nent myxoid stroma (Figure 3). Rich and delicate
branching capillary architecture was frequently
observed and sometimes vessel and perineural
invasions could be detected. As to pleomorphic
liposarcoma, it comprised of pleomorphic lipo  -
blasts in the background of plemorphic sarcoma.
The plemorphic round and spindled tumor cells
were mixed with multinucleated giant cells 
which were morphologically similar to malignant
Case no.A g e [years]G ender Primary sites Pathologic subtype Treatment Treatment outcome
1 21 Female Right parotid region Myxoid SE + PR NED
2 26 Female Right pharyngeal region ALT/WD SE NED
3 25 Female Left buccal region ALT/WD SE + PR R, D
4 11 Female Left buccal region Pleomorphic SE NED
5 8 Female Left ventral tongue Myxoid SE NED
6 46 Male Left palate Mixed-type SE NED
7 43 Female Left temporal region Myxoid SE NED
8 28 Female Left buccal region Mixed-type SE + PR NED
9 48 Female Right temporal region Myxoid SE + PR NED
10 39 Male Right parotid region ALT/WD SE NED
11 76 Male Left ventral tongue ALT/WD SE NED
ALT/WD – atypical lipmatous tumor/well differentiated liposarcoma, SE – surgical excision, SE + PR – surgical excision + postoperative radio-
therapy, NED – no evidence of disease, R – recurrence, D – death
Table I. Clinicopathological characteristics and treatment outcome of 11 oral and maxillofacial liposarcomas
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fibrous histocytoma (Figure 4). High mitotic activ-
ity and intramuscular invasion of tumor could be
observed. Mixed-type liposarcoma showed the
diverse morphological features of myxoid liposar-
coma and ALT/WD or pleomorphic liposarcoma in
the lesions with clear boundary. Among the mixed-
type lesions, different parts had their own char-
acteristic cell morphology and histopathological
features (Figure 5). 
Immunohistochemical staining results available
for 7 cases showed that vimentin and S-100 were
positive most cases. However, CD99, α-SMA, MSA,
CKp and Des commonly appeared negative (Table II).
Despite limited values for direct diagnosis for liposar-
coma based on immunohistochemical staining, these
results were valuable for differential diagnosis among
diverse types of malignancies. 
Discussion
Liposarcoma, first described by Virchow in 1857,
is considered as one of the most common soft tis-
sue sarcomas in adults. However, it rarely involves
the oral and maxillofacial region [9, 12]. Its rarity
and lack of characteristic symptoms and signs
reduced the opportunity to early detect and man-
agement [13]. The lack of adequate information
regarding the clinicopathological features and prog-
nostic factors for this rare tumor further makes ear-
ly diagnosis and treatment planning difficult. Our
data reported here may improve our understand-
ing of clinicopathological features of oral and max-
illofacial liposarcoma to avoid misdiagnosis and mis-
treatment in the clinic. 
Previous reports showed a male/female ratio of
about 2 : 1 for liposarcoma in the head and neck
Figure 1. ALT/WD liposarcoma in the right parotid region. A-B – Frontal and lateral view of a male patient with parotid
liposarcoma. C-D – MRI images showed a well-defined mass with irregular margins in the right parotid region and
extending toward parapharyngeal space (C – axial fat-suppressed T2 weighted, D – T2 weighted)
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region, indicating a male preponderance for this
tumor [2, 11]. However, an obvious female pre-
dominance (female/male: 8 : 3) was found in our
series. Similarly, Zheng et al. reported female pre-
ponderance with the female/male ratio of 4 : 1 in
their series of Chinese origin [5]. The discrepancy
of gender distribution may be due to limited num-
ber of cases analyzed and/or genetic in origin.
Moreover, the average age (33.7 years) in the Chi-
nese cohort is also lower than that in previous stud-
ies, as previous reports indicated the age of pres-
entation ranging from 30 and 60 years with a peak
in the sixth decades [14]. Notably, two female pae-
diatric patients with 8 and 11 years old were includ-
ed, being myxoid and pleomorphic subtype arising
from buccal mucosa and ventral tongue, respec-
tively. Pediatric liposarcoma is extremely unusual
and significantly different from adult cases. Alag-
gio et al. reported that conventional myxoid liposar-
coma was the most common subtype with excel-
lent prognosis in patients younger than 22 year of
age [15]. These two paediatric patients underwent
wide local excision with negative margins and had
no local recurrence and metastasis during the fol-
low-up. This finding reminds the clinicians that oral
and maxillofacial liposarcoma can even occur in chil-
dren and adolescent.
As the sites of predilection for oral liposarcomas,
the buccal mucosa is the most common site in this
series which is consistent with previous studies [16].
Of note, two parotid liposarcomas were found and
both were pathologically classified as ALT/WD. No
such lesions were found in minor salivary glands.
One patient was initially misdiagnosed as pleo-
morphic adenoma and inappropriately treated in
local hospitals, then developed recurrent lesion 
2 month later. To our knowledge, although ten cas-
es of liposarcomas in the parotid region were report-
ed in the English literature so far, only one case
with definitive diagnosis of parotid ALT/WD was
previously documented by Fanburg-Smith et al. with
unspecified treatment and no recurrence during 
2 years follow-up [9]. Therefore, our two cases
might add some important information to better
understanding of parotid ALT/WD and remind sur-
geons to be alert about the diagnosis and treatment
of such rare tumor in the parotid region.
The liposarcomas within oral and maxillofacial
region often appear as painless, slow-growing
swelling or soft-tissue masses. On the first exami-
nation, these disease entities tend to be perceived
as benign tumors. Three patients in this series had
initial misdiagnosis and incomplete excision and 
2 patients developed local recurrence before
Figure 2. Histopathological and immunohistochemical examination of ALT/WD liposarcoma. Mature adipocytes with
diverse size, multi-vacuolated lipoblasts and variable number of atypical stromal cells as showed by H + E staining
(A). Immunohistochemical staining for vimentin (B), S-100 (C), CD99 (D). Magnification 200×
D
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Figure 3. Histopathological and immunohistochemical examination of myxoid liposarcoma. Multivacuolated and
signet-ring primitive cells within the prominent myxoid stroma as showed by H&E staining (A). Magnification 100×.
Immunohistochemical staining for, S-100 (B), vimentin (C) CD34 (D). Magnification 400×
D
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C
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Figure 4. Histopathological examination of pleomorphic liposarcoma. The tumor consists of pleomorphic sarcoma
(left area) and pleomorphic lipoblasts (right area) as showed by H&E staining. Magnification 100× (A). The pleo-
morphic sarcoma is similar to malignant fibrous histocytoma and contains round and pleomorphic tumor cells with
mitosis. Magnification 400× (B). The lipoblasts shown nuclear atypia. Magnification 400× (C)
ABC
Figure 5. Histopathological examination of mixed-type (ALT/WD & myxoid) liposarcoma. The lesion consists of
ALT/WD (upper area) and myxoid liposarcoma (lower area) with apparent boundary as showed by H&E staining.
Magnification 100× (A). The ALT/WD (B) and myxoid part (C) each shows characteristic histology. Magnification 400×
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referred to our department. Therefore, differential
diagnosis of such masses is essential and should
include various benign and malignant lesions such
as lipomas, lymphadenopathies, branchial cyst and
Hodgkin lymphoma, et al. The presence of fat in CT
and MRI images may suggest a lipomatous tumor
such as lipoma and liposarcoma. Several charac-
teristic findings including more than 75% fat, thick
septa may contribute a lot to differential diagnosis
between lipoma and ALT/WD [17, 18]. However, it’s
fairly difficult to definitely diagnose such masses
between liposarcomas and other soft tissue neo-
plasm based on radiography. 
Histological examination of liposarcoma is piv-
otal for diagnosis establishment. Tumor cells with
characteristic morphology contribute to diagnosis
and subtype classifications. The most common his-
tologic subtypes in our series, in agreement with
previous findings, are ALT/WD and myxoid liposar-
coma. The lipogenic differentiation marker S-100,
indicative of the presence of lipoblasts, was stained
positive in ALT/WD and myxoid liposarcoma, but
negative in other subtypes. Although no specific
molecular markers exist for its diagnosis, howev-
er, such markers by immunohistochemistry may
be beneficial for differential diagnosis and subtype
classification. The cytogenetic feature of ALT/WD
and dedifferentiated liposarcoma has been
revealed in the form of supernumerary ring or giant
marker chromosomes with 12q13-15 amplification
[19]. Several tumor-associated genes including
MDM2, HMGA2 and CDK4 were identified and
proven beneficial for differential diagnosis by
immunohistochemical detection or fluorescent in
situ hybridization [20]. Moreover, fine needle aspi-
ration biopsy was suggested as a valuable and
promising technique for preoperative diagnosis
especially in the deep region [21]. Therefore, fur-
ther studies were warranted to determine the roles
of such tumor biomarkers in early detection, patho-
logical categorization and prognostic prediction for
liposarcoma [22].
Complete surgical excision with free margins is
the primary treatment option for liposarcomas [2,
9, 13]. The values of adjuvant radiotherapy and
chemotherapy for liposarcoma still remain contro-
versial. Radiotherapy alone is occasionally consid-
ered as an alternative for selected cases especial-
ly for impossible total excision or recurrent tumors.
Careful follow-up after complete excision has been
recommended for monitoring recurrence and dis-
tant metastasis. Local recurrence, usually resulting
from incomplete excision becomes a common chal-
lenge for successful management of liposarcoma.
Although these tumors sometimes appear well
encapsulated, wide excision should be emphasized
to avoid nay microscopic residual disease. In our
cases, excisions were performed at least 1.5 cm
from the palpable margins of lesions to guarantee
complete removal when possible. However, the
proximity of vital neurovascular structures and
ensuing severe morbidities caused by wide excision
sometimes limited the extent of excision. There-
fore, adjuvant postoperative radiotherapy is some-
times needed for selected cases especially when
complete excision was unattainable. It has been
suggested that radiotherapy delayed tumor growth
and prevented local recurrence [23]. Golledge et al.
reported that patients treated with surgery alone
had a 5-year survival rate of 83% as compared with
63% for those treated with combined surgery and
radiotherapy [2]. Four patients reported here under-
went surgery combined postoperative radiothera-
py and had satisfactory results without evidence of
recurrence. Based on our experience and previous
reports, adjuvant radiotherapy should be consid-
ered as a valuable treatment alternative for local
disease control after incomplete excision or suspi-
cious disease left. In addition, no study has offered
conclusive evidence supporting the treatment util-
ity of chemotherapy for liposarcoma.
Although previous studies suggested that tumor
size, histological subtype and treatment correlated
with biological behaviors and prognosis of liposar-
comas, we didn’t confidentially draw conclusions
about the relationship between prognosis and these
clinicopathological variables largely due to limited
number of cases. But, in general, oral and maxillo-
Case Vim S-100 CD34 CD99 α-SMA CKpE MAD es
1+ ++ –– –– –
4+ –––––– –
6+ ±––––– –
8+ ±+–––– –
9+ – ––––– –
10 + + – + – – – –
11 + + – ± – – – ±
Vim – vimentin, α-SMA – α-smooth muscle actin, MSA – muscle-specific actin, CKp – pan-cytokeratin, EMA – epithelial membrane antigen, 
Des – desmin, positive: +, negative: –, partial positive: ±
Table II. Immunohistochemical analyses of oral and maxillofacial liposarcomas
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facial liposarcomas had good prognosis as sup-
ported by our data and others findings, presumably
owing to easy detection and timely therapeutic
intervention.
In conclusion, we retrospectively reviewed 11 cas-
es of primary liposarcomas within oral and max-
illofacial region and described the clinicopatholog-
ical features and treatment outcomes in detail. Our
study indicated that these rare tumors developed
from various anatomic sites, most frequently in the
buccal mucosa and usually identified as ALT/WD
and myxoid subtypes by histopathology. The treat-
ment outcomes of these patients receiving surgery
or together with radiotherapy were favorable with
90.9% disease-free survival during the follow-up,
rare recurrence and no metastasis. It’s critically
essential for clinicians to keep the possible diag-
nosis of liposarcoma in mind when diagnosing
masses in the oral and maxillofacial region. More
retrospective and perspective studies are still need-
ed to establish the optimized diagnosis and treat-
ment regimes for oral and maxillofacial liposarco-
ma.
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